Catalyst Pharmaceuticals, Inc agreed to be sold to Angelini Pharma S.p.A, announced on May 7, 2026.
8-KJ.P. Morgan Securitiesfirm advised the seller.
8-KCenterview Partnersfirm, Morgan Stanley & Co.firm and BNP Paribas Securitiesfirm advised the buyer.
8-KThe filing puts the value at $4.1B.
8-KCenterview Partnersfirm's other recent deals include Surgery Partners, Incdeal on Oct 26, 2026.
8-K
Value
| Kind | Amount | Basis | Source |
|---|---|---|---|
| Disclosed | $4.1B | equity value | 8-K |
More deals with Centerview Partners
first 2 of 5
| Date | Deal | Firms | Source |
|---|---|---|---|
| Oct 26, 2026 | Surgery Partners, Inc · Sale | Jefferies, Centerview Partners | 8-K |
| Oct 8, 2026 | Pacira BioSciences, Inc · Sale | Morgan Stanley & Co., Goldman Sachs & Co. | 8-K |
More deals with J.P. Morgan Securities
first 2 of 5
| Date | Deal | Firms | Source |
|---|---|---|---|
| Oct 26, 2026 | Surgery Partners, Inc · Sale | Jefferies, Centerview Partners | 8-K |
| Oct 21, 2026 | American Oncology Network, Inc · Sale | Citigroup Global Markets, Moelis & Company | 8-K |
More deals with Morgan Stanley & Co.
first 2 of 5
| Date | Deal | Firms | Source |
|---|---|---|---|
| Oct 20, 2026 | Prudential of Brazil and Prudential of Mexico · Sale | Morgan Stanley & Co., Goldman Sachs & Co. | 8-K |
| Oct 19, 2026 | Trumid Holdings, LLC · Sale | Morgan Stanley & Co., Goldman Sachs & Co. | 8-K |